Sign in

CIK 0001714899 · Large accelerated filer

Denali Therapeutics Inc.

Sign in to watch
Ticker
DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
463872213
Phone
(650) 866-8547
Business address
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations
  5. 8-K Event Acquisition or sale completed
  6. 8-K Event Material agreement · Regulation FD disclosure
  7. 8-K Event Shareholder vote results
  8. 8-K Event Regulation FD disclosure
  9. 10-Q Report Quarterly Report
  10. 8-K Event Results of operations
  11. 8-K Event Agreement ended
  12. 8-K Event New debt or obligation · Regulation FD disclosure
  13. 8-K Event Regulation FD disclosure
  14. 10-K Report Annual Report
  15. 8-K Event Results of operations
  16. 8-K Event Regulation FD disclosure
  17. 8-K Event Material agreement · Other events
  18. 8-K Event Regulation FD disclosure · Other events
  19. 8-K Event Material agreement
  20. 10-Q Report Quarterly Report

Page 1 of 7 · 140 filings